Pharmacologic management of atrial fibrillation. - Wikidata - awgldk - TriplyDB

Pharmacologic management of atrial fibrillation.

Pharmacologic management of atrial fibrillation.

http://www.wikidata.org/entity/Q41561795

about

Pharmacologic management of atrial fibrillation.

http://www.wikidata.org/entity/Q41561795

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Pharmacologic management of atrial fibrillation.

@en

type

label

Pharmacologic management of atrial fibrillation.

@en

prefLabel

Pharmacologic management of atrial fibrillation.

@en

P1433

Q41561795-B01B57DE-1FB9-4382-82B5-B86715DB085C

P1476

Q41561795-56F93921-26AA-4A89-923C-913368E0FB87

P2093

Q41561795-0396F85A-7C6C-44B0-B440-BEDA28E08649

Q41561795-53BF6BFD-80A6-4617-9F76-301C5401E906

P2860

Q41561795-13397880-2620-4BC7-B58A-12F8FADE654C

Q41561795-1755305F-D6BF-43BF-B257-11FB8A79BC6F

Q41561795-333C2E83-E891-4C33-B3A2-A96F945A8C4E

Q41561795-45C5A1EE-1CBE-45C2-967F-D28B28528D4B

Q41561795-4D524A51-AC17-4D74-BBEC-7BD9A5A571E6

Q41561795-4E3A614C-055C-45D8-9351-E5ECBC8CCA9E

Q41561795-6303A049-75BA-4757-87A1-FD5FFDB18595

Q41561795-8249480F-CDC6-4FA4-99B7-10D6F86FEFBB

Q41561795-899063B9-9E87-4803-A175-0722C2739E0B

Q41561795-90CF0D9B-42B9-4FC7-8630-306EFD2FBE66

P304

Q41561795-3C3A4676-74B2-448A-9283-5E3D37FA9E7B

P31

Q41561795-09FB590D-3248-49F2-9F8B-279CAB7E4B0C

P356

Q41561795-423FF941-6EA9-4AB3-AD53-6FCD62AA7B97

P433

Q41561795-3FABF9D4-D4AA-4AA1-85B9-409314861D36

P478

Q41561795-A576A78A-FA22-4A0D-9086-E2DE8F32B3EA

P577

Q41561795-D0BC0E6A-5F1F-4B79-8854-E2C6EA90ED25

P698

Q41561795-C8CEBA4C-EA47-4ACC-99AB-4179E2601DCC

P356

J.1540-8167.1997.TB00841.X

P1433

Journal of Cardiovascular Electrophysiology

P1476

Pharmacologic management of atrial fibrillation.

@en

P2093

Pritchett EL

http://www.w3.org/2001/XMLSchema#string

Riley RD

http://www.w3.org/2001/XMLSchema#string

P2860

Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent

Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supra

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

Effect of digoxin on atioventricular conduction. Studies in patients with and without cardiac autonomic innervation.

Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study.

Digoxin for atrial fibrillation: a drug whose time has gone?

Efficacy and toxicity of amiodarone for the treatment of supraventricular tachyarrhythmias.

Relation between echocardiographically determined left atrial size and atrial fibrillation.

Verapamil and digoxin: their respective effects on atrial fibrillation and their interaction.

Prophylaxis of recurrent embolism of intracardiac origin; protracted anticoagulant therapy on an ambulatory basis.

P304

818-829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1540-8167.1997.TB00841.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

1997-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9255690

http://www.w3.org/2001/XMLSchema#string